Skip to content
PharmaInsight

Olmesartan medoxomil/amlodipine/hydrochlorothiazide

National NHS prescribing (Prescription Cost Analysis) · Hypertension and heart failure
Data updated March 2026

Olmesartan medoxomil/amlodipine/hydrochlorothiazide was ranked 887th of 1,794 medicines by items in March 2026, with 1,053 items, down 1.5% on a year earlier.

1,053items

Dispensed in March 2026

NHSBSA Prescription Cost Analysis

£18,865

Net ingredient cost · March 2026

NHSBSA PCA

12,957items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Olmesartan medoxomil/amlodipine/hydrochlorothiazide: national items dispensed by month

1,053

Source: NHSBSA Prescription Cost Analysis, to March 2026

Download CSV
Embed this chart

Top presentations, March 2026

The individual products dispensed under Olmesartan medoxomil/amlodipine/hydrochlorothiazide, by items this month.

Presentations of Olmesartan medoxomil/amlodipine/hydrochlorothiazide, March 2026
Presentation Items Net ingredient cost
Sevikar HCT 40mg/10mg/25mg tablets 514 £7,853
Sevikar HCT 20mg/5mg/12.5mg tablets 209 £4,403
Sevikar HCT 40mg/10mg/12.5mg tablets 172 £3,448
Sevikar HCT 40mg/5mg/25mg tablets 99 £1,971
Sevikar HCT 40mg/5mg/12.5mg tablets 59 £1,191

Compare Olmesartan medoxomil/amlodipine/hydrochlorothiazide with

Other medicines in the same BNF section, by prescribing volume.